<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03469687</url>
  </required_header>
  <id_info>
    <org_study_id>METC 04-112</org_study_id>
    <nct_id>NCT03469687</nct_id>
  </id_info>
  <brief_title>Symax International Study</brief_title>
  <official_title>5 Year Clinical and Radiographic Follow-up of the Uncemented Symax Hip Stem in an International Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vejle Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stryker Orthopaedics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The uncemented Symax hip stem is developed through optimization of the uncemented Omnifit hip
      stem. The Symax stem design combines an anatomical anteverted proximal geometry with a
      straight distal section. The proximal part is coated with a biomimetic hydroxyapatite (HA)
      coating for improved osseointegration to enhance load transfer and to minimize proximal bone
      loss. The distal part is treated with an anodization surface treatment in order to prevent
      distal bone apposition, which is expected to prevent distal loading and reduce proximal
      stress shielding. Aim of this study is to report mid-term clinical performance and evaluate
      whether the radiographic features are in line with the design principles of the Symax hip in
      an international clinical study with 5 years of follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2, 2004</start_date>
  <completion_date type="Actual">October 11, 2010</completion_date>
  <primary_completion_date type="Actual">October 11, 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Harris Hip Score (HHS) during follow-up</measure>
    <time_frame>Preoperative HHS and postoperatively change in HHS at 6 months, 1 year, 2 years, 3 years and 5 years</time_frame>
    <description>A hip specific functional score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic evaluations</measure>
    <time_frame>Immediately postoperative radiograhpic evaluation as baseline and changes in radiography at follow-up 6 months, 1 year, 2 years, 3 years and 5 years we evaluated the radiograhip evaluations again</time_frame>
    <description>Radiographic evaluations per Gruen zone and comparison between two assessment teams</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Hip Osteoarthritis</condition>
  <condition>Prosthesis Durability</condition>
  <arm_group>
    <arm_group_label>Symax uncemented hip stem</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The Symax hip stem is an uncemented design forged from Ti6Al4V alloy (Stryker EMEA). Primary mechanical stability is provided by anatomical metaphyseal geometry. The hip stem features a size dependent anteversion, neck length and offset, with a CCD angle of 128Â°. Secondary biological stability is accomplished by fast osseous integration due to the BONIT-HA coating on the metaphyseal part of the stem.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Symax uncemented hip stem</intervention_name>
    <arm_group_label>Symax uncemented hip stem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring uncemented primary total hip arthroplasty (osteoarthritis,
             avascular necrosis and/or post-traumatic arthritis), age between 18-70 years, BMI less
             or equal to 35.

        Exclusion Criteria:

          -  Patients with bilateral hip complaints, impaired cognitive function and use of
             medication or illness influencing bone metabolism.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>ten Broeke RH, Hendrickx RP, Leffers P, Jutten LM, Geesink RG. Randomised trial comparing bone remodelling around two uncemented stems using modified Gruen zones. Hip Int. 2012 Jan-Feb;22(1):41-9. doi: 10.5301/HIP.2012.9103.</citation>
    <PMID>22383318</PMID>
  </results_reference>
  <results_reference>
    <citation>ten Broeke RH, Alves A, Baumann A, Arts JJ, Geesink RG. Bone reaction to a biomimetic third-generation hydroxyapatite coating and new surface treatment for the Symax hip stem. J Bone Joint Surg Br. 2011 Jun;93(6):760-8. doi: 10.1302/0301-620X.93B6.24986.</citation>
    <PMID>21586774</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2018</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Hip</mesh_term>
    <mesh_term>Prosthesis Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyoscyamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

